ReviewViruses2026

Clinical and Pathophysiological Considerations Related to the Impact of Bulevirtide, a New Entry Inhibitor, in HBV-HDV Infection.

Raisa Eloise Barbu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.